WCM
VYGR icon

Weld Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Weld Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,463
Closed -$782K – 956
2019
Q3 		$782K Buy
45,463
+32,101
+240% +$674K 0.14% 232
2019
Q2 		$364K Sell
13,362
-6,440
-33% -$147K 0.07% 483
2019
Q1 		$379K Buy
19,802
+3,634
+22% +$47.3K 0.07% 455
2018
Q4 		$152K Buy
+16,168
New +$207K 0.03% 607

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Weld Capital Management's VYGR Position: Q4 2019 in Review

Weld Capital Management sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 45,463 shares — an estimated $782K sold.

Weld Capital Management first reported a position in VYGR in Q4 2018 and held it in 4 quarters. The position peaked at $782K in Q3 2019. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

  • Weld Capital Management reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Weld Capital Management sold 45,463 Voyager Therapeutics shares in Q4 2019, an estimated $782K.
  • Weld Capital Management first reported a position in Voyager Therapeutics in Q4 2018 and held it in 4 quarters.
  • Weld Capital Management's Voyager Therapeutics position peaked at $782K in Q3 2019.
  • 138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Weld Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.